ARCHIVES

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

In Brief: BCDDP “Dramatically” Changed U.S. Medical Practice, Fink Says; *% Not too uch-DeVita

December 15, 1978

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993